Does inhaled corticosteroid predispose asthmatic patients to diabetes?

Evaluating the Effects of Inhaled Corticosteroid on Insulin Sensitivity in Asthmatic Patient

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201605247411N2

Enrollment

Registered

2016-06-27

Start date

2014-07-02

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic lower respiratory diseases. Asthma

Interventions

Inhaled corticosteroid.

Treatment - Drugs

Inhaled corticosteroid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria included: age over 15 years; stage2 or 3 asthma; FEV1 above 60%; no previous use of oral or inhaled corticosteroid and no history of diabetes. Exclusion criteria included: history of diabetes or malignancy; pregnancy; acute infection; endocrine disorder; taking any medication that affects glucose metabolism; obesity (defined by BMI=30 kg/m2) and sleep apnea

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
FBs, BS2HPP, HbA1C, LDL, HDL, Insulin Level, CRP and HOMA-IR. Timepoint: at the beging of study and two months later. Method of measurement: examination.	—

Secondary

Measure	Time frame
FEV1, FVC, FEV1/FVC. Timepoint: At the begining of study and two months later. Method of measurement: Spirometry device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Hamid Borsi

Ahvaz Jundishapur University of Medical Sciences

seyedhamidborsi@yahoo.com+61 3 2216 5012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 24, 2026